Sandy Liebhard

Sandy A. Liebhard, a founding partner at Bernstein Liebhard LLP, has successfully represented plaintiffs in complex litigations for more than 20 years. As dedicated consumer advocates, Mr. Liebhard and his fellow attorneys have taken on some of the largest corporate interest in the nation in cases involving dangerous pharmaceuticals, faulty medical devices and defective consumer products. As an author for RXInuryHelp.com, Mr. Liebhard has written extensively on the litigation involving proton pump inhibitors (Nexium, Prilosec, PrevAcid, etc.) and kidney injuries; Risperdal and gynecomastia; the Bair Hugger forced air warming blanket; talcum powder and ovarian cancer; transvaginal mesh; power morcellators; defective hip implants; and more.

Mr. Liebhard is a 1988 graduate of Brooklyn Law School. He is admitted to the Bar of the State of New York, as well as the United States District Courts for the Southern and Eastern Districts of New York.


Gadolinium Contrast Dye Lawsuits Could be Centralized in Single Federal Court

The growing number of lawsuits filed over Gadolinium Deposition Disease, a complication allegedly caused by certain MRI contrast dyes, could soon be consolidated in a single federal court. 20+ Gadolinium MRI Lawsuits Pending, But Plaintiffs Predict Hundreds More Will be … Continue reading

Knee Replacement Lawsuit News: Texas Man Claims DePuy Attune Knee Prone to Early Failure

A Texas man has become one of the most recent plaintiffs to file a lawsuit over DePuy Synthes’s Attune Knee System. Plaintiff Claims “Unreasonable Risk” of Attune Knee Complications was Concealed According to a complaint filed in the U.S. District … Continue reading

Ethicon Physiomesh Lawsuits Consolidated in New Jersey’s Atlantic County Superior Court

The New Jersey Supreme Court has agreed to create a Multicounty Litigation for hernia mesh lawsuits involving injuries and complications allegedly associated with Ethicon, Inc.’s Physiomesh Flexible Composite mesh implants. According to a Notice issued on August 15th, all such claims … Continue reading

Court Overseeing Federal Testosterone Lawsuits Reports Finalization of Androderm Settlement

The federal court overseeing thousands of testosterone treatment lawsuits reported last month that the manufacturer of Androderm has finalized a settlement with more than 500 men who claim their use of the medication caused heart attacks, blood clots, and other … Continue reading

South Korea Bans Certain Gadolinium MRI Contrast Dyes Amid Safety Concerns

As gadolinium MRI contrast dye lawsuits continue to mount in courts throughout the United States, concerns that the drugs might accumulate in the brain have prompted health regulators in South Korea to announce a temporary ban on linear gadolinium agents. … Continue reading

Court Overseeing Federal Proton Pump Inhibitor Lawsuits Establishes Protocols for Defendant Fact Sheets

Nexium lawsuits and other kidney injury claims involving a class of heart burn drugs called proton pump inhibitors continue to move forward in a multidistrict litigation now underway in the U.S. District Court, District of New Jersey. On July 30th, … Continue reading

Parties to Atrium C-Qur Hernia Mesh Lawsuits Select Bellwether Trial Candidates

The federal litigation involving hundreds of hernia mesh lawsuits filed on behalf of individuals allegedly injured by Atrium Medical’s C-Qur devices continues to prepare for bellwether trials. According to a Joint Notice filed in the U.S. District Court, District of … Continue reading

Onglyza Lawsuit Claims AstraZeneca Hid Saxagliptin Heart Failure Risks

A plaintiff from Georgia has filed a new Onglyza lawsuit that accuses AstraZeneca of concealing the potential for heart failure and other side effects allegedly associated with saxagliptin, the active ingredient in the Type 2 diabetes medication. Plaintiff Would Not … Continue reading

Additional Manufacturer Added to Valsartan Heart Drug Recall

The U.S. Food & Drug Administration (FDA) has added tablets marketed by another manufacturer to the massive valsartan recall for blood pressure and heart medications that may contain a cancer-causing chemical. Camber Pharmaceuticals Valsartan Recall The recall expansion was announced … Continue reading

Bard Hernia Mesh Lawsuits Consolidated in Ohio Federal Court

A federal judicial panel has agreed to create a multidistrict litigation for all federally-filed hernia mesh lawsuits involving polypropylene devices marketed by C.R. Bard, Inc. and its Davol, Inc. subsidiary. More than 100 Bard Hernia Mesh Lawsuits Pending in Federal … Continue reading

Follow Us

RXInjuryHelp.com on Google+  RXInjuryHelp.com on Facebook  RXInjuryHelp.com on LinkedIn  RXInjuryHelp.com on Twitter  RXInjuryHelp.com on YouTube  RXInjuryHelp.com on Pinterest

Skip to content